ENGLISH
|
JAPANESE
|
CONNECT WITH US:
Home
About
Contact
Log in
*
Home
Press release
2020年01月27日 09時02分
Exvisa Launches Immigration App Designed to Change How People Move Across the Globe
DUSSELDORF, GERMANY, 2020年01月27日 - (JCN Newswire) - Exvisa GmbH is proud to announce the launch of its new immigration app, designed to change how people move across the globe in an increasingly digital world. Tolga Akcay, Exvisa CEO, says his company is transforming the immigration system, along with its counterparts, emigration and relocation. Exvisa is a comprehensive technology that effectively and safely digitizes our passports, visas, and immigration information, transforming the way that people look at traveling, immigrating, and crossing borders.
"Exvisa is more than a simple digitization process for your visa or your passport - it's a comprehensive travel technology that makes it easier than ever before for businesses and state entities to search for potential beneficial immigrants - those who possess certain skillsets or experience that are in need. In addition, Exvisa is the world's most secure, safe, and protected digital travel platform, with cryptonizing technology specifically designed to ensure that your documents cannot be hacked, stolen, or compromised.
"First, let's talk about the most advanced level of immigration protection that countries can now take advantage of thanks to this new technology. Because Exvisa digitizes and cryptonizes travel documents like visas and passports, countries can leverage the tremendous power of the intelligent system to effectively control relocation, immigration, or emigrations processes through a series of user-intuitive parameters that give authorities the comprehensive control that they've always wanted.
"Exvisa was built on the world's most advanced intelligent system to ensure that it could offer a wide range of benefits that extended far beyond the process of digitizing documents. I wanted it to have a real-world application. So far, we've seen first-hand just how powerful of a resource it can be for countries who want to gain more comprehensive control over their immigration, relocation, and emigration procedures. The system makes it easier for authorities to ensure that all necessary documents are legitimate and applicable for any new immigrants, while also helping to reduce any risks associated with immigration," says Tolga.
Exvisa can also be applied by large international corporations and employed as a talent acquisition or talent screening resource. For outsourcing needs, companies can utilize the power of Exvisa to identify specialized professionals in other countries whom they may want to recruit for their own purposes. For instance, if your business in Germany is running short on, say, programmers, you can work with countries like the US or China to cover your shortage and ensure that you have access to the talent that you need to deliver your services.
In the next few years, Exvisa will likely become the new standard instrument for immigration, relocation, and emigration. With the most advanced levels of security and protection, widespread application for businesses, comprehensive immigration control for government entities, and an easier, more convenient means for people looking to immigrate, emigrate, or relocate, Exvisa successfully leverages the power of intelligent digital technology to bring a much-needed solution to an increasingly complicated global problem.
Exvisa GmbH
Tolga Akcay
+49 211 5405 7101
t.akcay@exvisa.com
http://www.exvisa.com
セクター: トラベル
Copyright ©2025 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.
Latest Release
The 26th Hong Kong Forum marks successful completion
Dec 03, 2025 22:44 JST
Mitsubishi Motors Launches the All-New Destinator in Vietnam
Dec 03, 2025 18:00 JST
Anime Tokyo Station: Celebrating the 25th Anniversaries of Two Popular Anime with an Anniversary Joint Exhibition Starting November 15
Dec 03, 2025 11:30 JST
Eisai Presents New Data on Anti-Tau Antibody Etalanetug (E2814) at CTAD 2025
Dec 03, 2025 00:01 JST
NEC Launches AI Agent Service in Japan to Automate Procurement Negotiations Using AI
Dec 02, 2025 23:43 JST
Fujitsu develops new technology to support human-robot collaboration
Dec 02, 2025 23:26 JST
Fujitsu establishes international consortium to tackle disinformation/misinformation and new AI risks
Dec 02, 2025 22:55 JST
Fujitsu achieves high-precision, long-duration molecular dynamics simulation for all-solid-state battery interphases with over 100,000 atoms
Dec 01, 2025 23:04 JST
Fujitsu develops multi-AI agent collaboration technology to optimize supply chains, launches joint trials
Dec 01, 2025 22:43 JST
Fujitsu launches 'Fujitsu Accelerator Program for SPORTS' to create new value through Sports x Technology
Dec 01, 2025 22:14 JST
Eisai Submits New Drug Application for Subcutaneous Formulation of "LEQEMBI(R)" for the Treatment of Early Alzheimer's Disease in Japan
Nov 28, 2025 23:00 JST
JFCR, NEC, and Taiho to Develop Cancer Vaccines Utilizing Whole-Genome Information
Nov 28, 2025 19:41 JST
MHI Publishes "MHI REPORT 2025" and "SUSTAINABILITY DATABOOK 2025"
Nov 28, 2025 19:05 JST
Sharp Wins IAM's "Asia IP Elite 2025", Awarded to Companies with Outstanding Intellectual Property Strategy for The Second Consecutive Year
Nov 28, 2025 18:36 JST
Fujitsu builds platform for NSK to create environmental value throughout the product lifecycle of bearing products
Nov 28, 2025 18:01 JST
Fujitsu launches Japan Edition of SAP Fioneer Cloud for Insurance, a next-generation platform supporting core business operations in the Japanese insurance industry
Nov 28, 2025 17:28 JST
NEC Launches Sales Support Solution Utilizing Agentic AI
Nov 27, 2025 22:31 JST
Fujitsu and Yamaguchi University develop low-power edge computing technology for near real-time image processing on small satellites
Nov 27, 2025 22:00 JST
World's first ever spiral escalator renewal project conducted at a commercial facility in Mexico
Nov 27, 2025 11:00 JST
Eisai Completes Rolling Submission to US FDA for LEQEMBI(R) IQLIK(TM) (lecanemabirmb) Supplemental Biologics License Application as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer's Disease Under Fast Track Status
Nov 26, 2025 19:42 JST
More Latest Release >>